These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6243043)
1. Central effects of vasopressin in man. Audibert A; Moeglen JM; Lancranjan I Int J Neurol; 1980; 14(2-4):162-74. PubMed ID: 6243043 [No Abstract] [Full Text] [Related]
2. Pituitary hormones and amnesia. Rigter H; Van Riezen H Curr Dev Psychopharmacol; 1979; 5():67-124. PubMed ID: 219989 [TBL] [Abstract][Full Text] [Related]
3. Hormone-induced alteration in brain transmitter metabolism and brain function. Telegdy G Endocrinol Exp; 1982 Nov; 16(3-4):217-27. PubMed ID: 6129128 [No Abstract] [Full Text] [Related]
4. "Hormones that improve memory": a waiting game. Zoler ML Geriatrics; 1983 Jul; 38(7):101, 104-5. PubMed ID: 6303909 [No Abstract] [Full Text] [Related]
5. Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia. Walter R; Hoffman PL; Flexner JB; Flexner LB Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4180-4. PubMed ID: 1060098 [TBL] [Abstract][Full Text] [Related]
6. The effect of neurohormones on the brain and the endocrine system. Telegdy G Acta Physiol Acad Sci Hung; 1980; 55(4):273-81. PubMed ID: 6110309 [TBL] [Abstract][Full Text] [Related]
7. The effects of vasopressin on memory processes: the role of noradrenergic neurotransmission. Kovács GL; Bohus B; Versteeg DH Neuroscience; 1979; 4(11):1529-37. PubMed ID: 42026 [No Abstract] [Full Text] [Related]
8. [Therapeutic action of vasopressin in amnesic syndromes and their possible action in depression]. Oliveros JC; Jandali MK Arch Neurobiol (Madr); 1978; 41(1):63-74. PubMed ID: 697515 [No Abstract] [Full Text] [Related]
9. The hypothalamic-pituitary-adrenocortical system. Brodish A; Lymangrover JR Int Rev Physiol; 1977; 16():93-149. PubMed ID: 20421 [No Abstract] [Full Text] [Related]
10. Modulation of memory by pituitary hormones and related peptides. Rigter H; Crabbe JC Vitam Horm; 1979; 37():153-241. PubMed ID: 232793 [No Abstract] [Full Text] [Related]
11. [Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases]. Bakharev VD; Tikhomirov SM Sov Med; 1984; (6):50-3. PubMed ID: 6147020 [No Abstract] [Full Text] [Related]
12. Can drugs halt memory loss? Kent S Geriatrics; 1981 Feb; 36(2):34-42. PubMed ID: 6778776 [No Abstract] [Full Text] [Related]
14. [Effects of a vasopressin-corticoid association in patients having an astrocytoma or cerebral metastasis. Evolutive study using complementary methods]. Bernard-Weil E; David M; Pertuiset B; Hirsch JF; Fischgold H Neurochirurgia (Stuttg); 1968 Sep; 11(5):189-99. PubMed ID: 4306909 [No Abstract] [Full Text] [Related]
15. What is the mechanism of vasopressin in causing corticotropin release? Franzén G Endokrinologie; 1971 Apr; 57(3):338-42. PubMed ID: 4325993 [No Abstract] [Full Text] [Related]
16. Role of oxytocin in memory and amnesia. Kovács GL; Telegdy G Pharmacol Ther; 1982; 18(3):375-95. PubMed ID: 6132415 [No Abstract] [Full Text] [Related]
17. Chemical communication in the CNS: neurotransmitters and their function. Bloom FE Prog Brain Res; 1983; 58():3-9. PubMed ID: 6138811 [No Abstract] [Full Text] [Related]
18. Vasopressin and physostigmine in the treatment of amnesia. Franceschi M; Tancredi O; Savio G; Smirne S Eur Neurol; 1982; 21(6):388-91. PubMed ID: 6756927 [No Abstract] [Full Text] [Related]
19. Neurochemistry of learning and memory: an evaluation of recent data. Dunn AJ Annu Rev Psychol; 1980; 31():343-90. PubMed ID: 6102451 [No Abstract] [Full Text] [Related]
20. [Mechanism of action and indications for psychopharmaceutic agents; possibilities and limitations in the elderly]. Verhoeven WM Gerontologie; 1981 Aug; 12(3):126-38. PubMed ID: 6115793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]